Clough Capital Partners L P Kymera Therapeutics, Inc. Transaction History

Clough Capital Partners L P

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 16, 2022	SELL	$14.13 - $42.55 $2.62 Million - $7.9 Million	-185,700 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$35.3 - $64.68 $3.01 Million - $5.52 Million	-85,300 Reduced 31.48%	185,700 $7.86 Million
Q3 2021 Nov 15, 2021	BUY	$47.8 - $66.66 $8.15 Million - $11.4 Million	170,400 Added 169.38%	271,000 $15.9 Million
Q2 2021 Aug 16, 2021	BUY	$31.08 - $51.95 $3.13 Million - $5.23 Million	100,600 New	100,600 $4.88 Million

184

64.4M

50.6K

81.7K

Ticker KYMR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,705,800
Market Cap $2.41B
Description
Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...

Get notified when there are updates to the investment portfolio of Clough Capital Partners L P, based on Form 13F filings with the SEC.

Stay updated on Clough Capital Partners L P with notifications on news.